Besides, ginsenoside Rb3 was screened as the novel inhibitor of KMO, and it also exhibited an excellent therapeutic effect on myocardial ischemia by maintaining mitochondrial fusion and fission balance. The gene discussed is KMO; the disease is myocardial ischemia.